Cookie Consent by TermsFeed

Oxford/AstraZeneca vaccine up to 90% effective

Oxford/AstraZeneca vaccine up to 90% effective

As the race to develop and approve a Coronavirus vaccine continues to make significant progress, it has been announced that a vaccine developed by the University of Oxford and AstraZeneca could be up to 90% effective.

Interim data about a trial of the vaccine has shown that the vaccine can offer around 70.4% protection, though researchers have said that protection could be as high as 90% depending on the dose given to members of the public.

The vaccine is significantly cheaper and easier to store and transport than the Pfizer and Moderna vaccines which have been developed, those these vaccines are thought to provide 95% protection.

Speaking about the announcement of the trial data on Twitter, Health Secretary Matt Hancock said "the whole country will be cheered by the news", adding "If approval is granted, the NHS will be ready to deliver".

UK Prime Minister Boris Johnson described the news as "incredibly exciting", while Labour leader Sir Keir Starmer has described the news as "really promising" and has called on the Government to appoint a dedicated vaccine minister.

The trials of the vaccine took place in the UK and Brazil and included around 20,000 volunteers. 

The UK Government has already ordered 100 million doses of the vaccine, on top of orders for other potential vaccines. 4 million doses of the Oxford vaccine are already in the UK, ready to be distributed subject to approval by regulator processes which are expected to take place in the coming weeks.


Follow Us On Social Media!

For the latest top political news, features and content, follow us at @speakerpolitics.